Literature DB >> 943180

Reactivity of fibrinogen and fibrinopeptide A containing fibrinogen fragments with antisera to fibrinopeptide A.

R E Canfield, J Dean, H L Nossel, V P Butler, G D Wilner.   

Abstract

Two antisera used in the radioimmunoassay for human fibrinopeptide A (FPA) which appear to have different immunochemical specificities have been tested for cross-reactivity with fibrinogen and with three fragments of fibrinogen which contain the FPA sequence. These fragments were the three-chain, NH2-terminal disulfide knot (N-DSK) produced by CNBr cleavage of fibrinogen, the reduced, carboxymethyl Aalpha chain portion of the N-DSK, and fragment E produced by plasmin digestion of fibrinogen. One antiserum (R-2) showed high specificity for free FPA and less than 2% cross-reactivity with fibrinogen or the FPA-containing fragments. The other antiserum (R-33) possessed a much higher degree of cross-reactivity with the FPA-containing fragments. Synthetic and native fibrinopeptides were found to be indistinguishable in the assay system with either antiserum. As a result of these studies, an hypothesis has been developed concerning the nature of the antigenic determinants on FPA which favor measurement of free FPA and limit cross-reactivity with larger, FPA-containing peptides.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 943180     DOI: 10.1021/bi00651a004

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  5 in total

1.  Urokinase has direct catalytic activity against fibrinogen and renders it less clottable by thrombin.

Authors:  J I Weitz; B Leslie
Journal:  J Clin Invest       Date:  1990-07       Impact factor: 14.808

2.  Clot-bound thrombin is protected from inhibition by heparin-antithrombin III but is susceptible to inactivation by antithrombin III-independent inhibitors.

Authors:  J I Weitz; M Hudoba; D Massel; J Maraganore; J Hirsh
Journal:  J Clin Invest       Date:  1990-08       Impact factor: 14.808

3.  Plasma levels of elastase-specific fibrinopeptides correlate with proteinase inhibitor phenotype. Evidence for increased elastase activity in subjects with homozygous and heterozygous deficiency of alpha 1-proteinase inhibitor.

Authors:  J I Weitz; E K Silverman; B Thong; E J Campbell
Journal:  J Clin Invest       Date:  1992-03       Impact factor: 14.808

4.  Human tissue-type plasminogen activator releases fibrinopeptides A and B from fibrinogen.

Authors:  J I Weitz; M K Cruickshank; B Thong; B Leslie; M N Levine; J Ginsberg; T Eckhardt
Journal:  J Clin Invest       Date:  1988-11       Impact factor: 14.808

5.  Development of an assay for in vivo human neutrophil elastase activity. Increased elastase activity in patients with alpha 1-proteinase inhibitor deficiency.

Authors:  J I Weitz; S L Landman; K A Crowley; S Birken; F J Morgan
Journal:  J Clin Invest       Date:  1986-07       Impact factor: 14.808

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.